Clinical trial
PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in…
NCT00259441 · Seoul National University Hospital, Other · Completed
Key facts
| NCT number | NCT00259441 |
|---|---|
| Title | PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography |
| Official title | Prevention of Radiocontrast Media Induced Nephropathy by Short-Term High-Dose Statin in Renal Insufficiency Undergoing Coronary Angiography (PROMISS) |
| Lead sponsor | Seoul National University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure |
| Intervention type | Drug |
| Interventions | Simvastatin |
| Enrollment | 320 |
| Start date | Feb 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Nov 29, 2005 |
| Last update posted | Jul 12, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: